Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches

• Main Authors: Giovanni Ostuzzi (Author), Chiara Gastaldon (Author), Davide Papola (Author), Andrea Fagiolini (Author), Serdar Dursun (Author), David Taylor (Author), Christoph U. Correll (Author), Corrado Barbui (Author)
• Format: Book
• Published: SAGE Publishing, 2020-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

People with coronavirus disease (COVID-19) might have several risk factors for delirium, which could in turn notably worsen the prognosis. Although pharmacological approaches for delirium are debated, haloperidol and other first-generation antipsychotics are frequently employed, particularly for hyp...